title: Infective endocarditis in renal transplant recipients.
abstract: Because of the increasing number of renal transplantations performed and the rarity of reported cases of infective endocarditis in these patients, we studied the clinical characteristics of this infection in this population. We report on two cases from our experience and review reported cases of infective endocarditis in renal transplant recipients retrieved from the MEDLINE system. In addition, we reviewed a large series of infective endocarditis looking for patients with renal transplants. In addition to our 2 cases, 12 previously reported cases were found. The mean time from transplantation to diagnosis of infective endocarditis was 3.5 years (range 2 months to 15 years). Causative organisms included fungi, Staphylococcus aureus (3 cases each), Corynebacterium sp. (2 cases), Streptococcus viridans, VRE, Brucella sp., Clostridium sp., Nocardia sp. and Erysipelothrix sp. (one case each). Skin manifestations of endocarditis and/or splenomegaly were not reported in these patients. Septic emboli and mycotic aneurysms were relatively common. The overall mortality rate was 50% (7 of 14 patients died). Infective endocarditis seems to be rare in renal transplant recipients. The few reported cases are characterized by unusual causative micro-organisms and atypical clinical presentation. Further studies are needed to delineate the magnitude and scope of this association.
authors: Department of Internal Medicine C, Rabin Medical Center, Beilinson Campus, Sackler School of Medicine, Tel Aviv University, Petach Tikvah, Israel.
authors: J
authors: J
authors: Bishara
authors: E
authors: E
authors: Robenshtok
authors: M
authors: M
authors: Weinberger
authors: M
authors: M
authors: Yeshurun
authors: A
authors: A
authors: Sagie
authors: S
authors: S
authors: Pitlik
mesh_terms: D000328:Adult; D017347:Brucella melitensis / Q000302:isolation & purification; D002006:Brucellosis / Q000175:diagnosis / Q000188:drug therapy; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000175:diagnosis* / Q000188:drug therapy*; D004888:Erysipelothrix / Q000302:isolation & purification; D004889:Erysipelothrix Infections / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D016239:MEDLINE; D008297:Male; D011183:Postoperative Complications; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D002511:Cephalosporins; D002443:Ceftriaxone; D004318:Doxycycline; D012293:Rifampin